• MMED share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • Price change

    The price of MMED shares has decreased $0.24 since the market last closed. This is a 1.09% drop.

  • Last closed at $21.79.

Key terms

About MMED

MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
  • Market cap: $6.13B

    A market capitalization between $2 billion and $10 billion places MMED in the mid-capitalization category.

Key terms

Smart score

Latest MMED news

Sep 18, 2026 8:28am ET Morgan Stanley Sticks to Its Buy Rating for MiniMed Group, Inc. (MMED) by TipRanks Sep 17, 2026 8:45am ET Largest borrow rate increases among liquid names by TipRanks Sep 15, 2026 8:16pm ET MiniMed Group Earnings Call Signals Strong Growth Momentum by TipRanks Sep 14, 2026 11:45am ET Analyst Initiates Buy on MiniMed, Citing Attractive Valuation and Favorable Medtronic Share-Exchange Structure by TipRanks Sep 14, 2026 7:35am ET MiniMed files S-4 in connection with Medtronic exchange offer by TipRanks Sep 14, 2026 7:35am ET Medtronic launches exchange offer to complete separation of MiniMed by TipRanks Sep 09, 2026 6:36am ET Wells Fargo Sticks to Their Buy Rating for MiniMed Group, Inc. (MMED) by TipRanks Sep 03, 2026 8:37am ET MiniMed price target raised to $21 from $19 at Morgan Stanley by TipRanks Sep 02, 2026 12:25pm ET MiniMed Flex-Driven Pump Reacceleration and CGM Upside Underpin Buy Rating Amid Valuation Discount by TipRanks Sep 02, 2026 10:06am ET MiniMed rises 8.6% by TipRanks Sep 02, 2026 9:20am ET MiniMed price target raised to $25 from $20 at Deutsche Bank by TipRanks Sep 02, 2026 8:05am ET MiniMed price target raised to $27 from $20 at Evercore ISI by TipRanks Sep 02, 2026 7:45am ET MiniMed Group: Strong FY27 Momentum and Accelerated Patch Pump Timeline Support Unchanged $19 Price Target and Buy Rating by TipRanks Sep 02, 2026 7:36am ET MiniMed price target raised to $26 from $21 at Mizuho by TipRanks Sep 02, 2026 7:35am ET MiniMed price target raised to $28 from $25 at UBS by TipRanks Sep 02, 2026 7:05am ET MiniMed price target raised to $28 from $25 at BTIG by TipRanks Sep 02, 2026 6:36am ET MiniMed price target raised to $28 from $24 at BofA by TipRanks Sep 02, 2026 6:30am ET Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Upstream Bio, Inc. (UPB) by TipRanks Sep 02, 2026 6:20am ET MiniMed price target raised to $26 from $23 at Citi by TipRanks Sep 02, 2026 5:16am ET Analyst Travis Steed Reiterates Buy on MiniMed, Boosts Price Target from $24 to $28 on Strong Growth Outlook and Pipeline Acceleration by TipRanks Sep 01, 2026 7:00pm ET MiniMed price target raised to $26 from $22 at Wells Fargo by TipRanks Sep 01, 2026 12:05pm ET MiniMed rises 11.3% by TipRanks Sep 01, 2026 12:01pm ET Midday Fly By: Medtronic reports Q1 beat, Ternus takes over as Apple CEO by TipRanks Sep 01, 2026 11:25am ET MiniMed jumps after upping fiscal 2027 organic growth outlook by TipRanks Sep 01, 2026 9:00am ET Morning Movers: Fervo Energy boosted by power purchase agreement with Google by TipRanks Sep 01, 2026 6:55am ET MiniMed reports Q1 EPS 0c, consensus 9c by TipRanks Aug 25, 2026 8:35am ET MiniMed: Buy Rating Backed by Strong CGM Adoption, New Flex Platform Rollout, and EBITDA Growth Potential by TipRanks Aug 17, 2026 9:10am ET MiniMed announces Flex system shipping in the U.S. with Instinct sensor by TipRanks Aug 10, 2026 10:10am ET Analysts’ Top NA Picks: SpaceX (SPCX), MiniMed Group, Inc. (MMED) by TipRanks Aug 10, 2026 9:20am ET MiniMed price target raised to $24 from $20 at BofA by TipRanks Jul 28, 2026 8:21am ET MiniMed initiated with a Buy at UBS by TipRanks
Apr 28, 2026 9:05am ET MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System by GlobeNewswire Apr 28, 2026 9:05am ET MiniMed annonce l’homologation par Santé Canada du capteur Simplera Sync🅪 et l’indication pour le diabète de type 2 avec le système MiniMed🅪 780G by GlobeNewswire

MMED Financials

1-year income & revenue

  • MMED total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • MMED net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • MMED earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

MMED Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MMED Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    MMED's competitors are included in the Health Technology sector and Medical Specialties group

  • Market cap: $6.13B

    A market capitalization between $2 billion and $10 billion places MMED in the mid-capitalization category.

Key terms

Latest investing news